SOUND SHORE MANAGEMENT INC /CT/: TEVA PHARMACEUTICAL INDS LTD (TEVA): Quarterly 13F Position History
As of Q1 2026, SOUND SHORE MANAGEMENT INC /CT/ reported 3,885,683 shares of TEVA PHARMACEUTICAL INDS LTD (TEVA), worth $117.0M and representing 3.9% of its 13F equity book. Quarter-over-quarter share count change: 424,223 (-9.8%) . The position first appeared in Q3 2023 and has been disclosed across 11 13F-HR filings in Pactolio's tracked window.
- 3,885,683Shares Held (Latest Filing)
- $117.0MReported Market Value (Latest Filing)
- 3.9%Portfolio Weight (% of 13F Equity Book)
- 424,223Quarter-over-Quarter Share Change
- -$17.5MQuarter-over-Quarter Value Change
- 8,919,234Peak Reported Shares (Historical)
Quarterly 13F-HR Disclosure History Source: SEC 13F-HR filings, 11 quarter s
| Quarter | Shares | QoQ Share Change | Share Change (%) | Market Value | Weight | Implied Price |
|---|---|---|---|---|---|---|
| Q1 2026 | 3,885,683 | 424,223 | -9.8% | $117.0M | 3.9% | $30.1 |
| Q4 2025 | 4,309,906 | 1,337,543 | -23.7% | $134.5M | 4.3% | $31.2 |
| Q3 2025 | 5,647,449 | 199,063 | -3.4% | $114.1M | 3.8% | $20.2 |
| Q2 2025 | 5,846,512 | +394,423 | +7.2% | $98.0M | 3.3% | $16.8 |
| Q1 2025 | 5,452,089 | +679,377 | +14.2% | $83.8M | 2.9% | $15.4 |
| Q4 2024 | 4,772,712 | 1,204,132 | -20.1% | $105.2M | 3.5% | $22.0 |
| Q3 2024 | 5,976,844 | 784,602 | -11.6% | $107.7M | 3.5% | $18.0 |
| Q2 2024 | 6,761,446 | 733,244 | -9.8% | $109.9M | 3.7% | $16.3 |
| Q1 2024 | 7,494,690 | 1,424,544 | -16.0% | $105.8M | 3.3% | $14.1 |
| Q4 2023 | 8,919,234 | +998,522 | +12.6% | $93.1M | 3.2% | $10.4 |
| Q3 2023 | 7,920,712 | — | — | $80.8M | 3.1% | $10.2 |
Methodology & FAQ
How This Position History Is Sourced
Each row is one SEC Form 13F-HR filing disclosing this position. Share count, market value, and reported quarter are taken verbatim from the filing; portfolio weight is recomputed against the same filing's total reported equity book. Implied price-per-share is market value divided by shares — a quarter-end mark, not the manager's cost basis. See the full methodology document for the normalization rules.
When did SOUND SHORE MANAGEMENT INC /CT/ first disclose a TEVA position in 13F-HR filings?
SOUND SHORE MANAGEMENT INC /CT/ first reported TEVA PHARMACEUTICAL INDS LTD (TEVA) on its 13F-HR filing for the period ending 2023-09-30 (Q3 2023). The position has appeared on 11 reported quarters within Pactolio's tracked window.
What was SOUND SHORE MANAGEMENT INC /CT/'s most recent quarter-over-quarter share-count change in TEVA?
Between Q4 2025 and Q1 2026, SOUND SHORE MANAGEMENT INC /CT/ reduced its TEVA position by 424,223 shares (-9.8%), leaving 3,885,683 shares at a market value of $117.0M.
Does the implied price-per-share represent SOUND SHORE MANAGEMENT INC /CT/'s cost basis in TEVA?
No. The implied price-per-share column is the 13F-HR reported market value divided by reported share count on the filing date (end of quarter). It is a quarter-end mark, not a cost basis or transaction price. Use it as a sanity check on the value column, not as an indicator of the manager's entry or exit price.